Form 4: Zura Bio Director Amit Munshi Increases Stake with $159,744 Share Purchase
SEC Form 4
Director Amit Munshi acquired 159,744 Class A ordinary shares of Zura Bio Ltd at $3.13 per share, increasing his total holdings to 777,384 shares.
Summary
- On April 22, 2024, Amit Munshi, a director of Zura Bio Ltd, purchased 159,744 Class A ordinary shares.
- The shares were acquired at a price of $3.13 per share, totaling $159,744.
- This transaction increased Munshi's direct ownership to 777,384 shares.
- The purchase was made through a private placement transaction as part of a Securities Purchase Agreement dated April 18, 2024.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as a director is increasing their stake in the company, which is generally seen as a good sign. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Directors purchasing shares in their own company is a common practice and is often viewed positively by investors. It signals that the director believes in the company's future prospects and is willing to invest their own money.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive signal, potentially increasing confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of the Securities Purchase Agreement between Zura Bio Ltd and Amit Munshi. |
| 04/22/2024 | Date of the transaction where Amit Munshi purchased Class A ordinary shares. |
| 04/24/2024 | Date of signature by Attorney-in-Fact, Kim Davis. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.